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ABSTRACT 
Objective: Diet-induced hyperlipidemia and obesity are the major risk factors for type II diabetes mellitus, hypertension, musculoskeletal and 
cardiovascular disorders (CVD). The objective of the present study is to furnish scientific proof for the lipid-lowering effect of β-glucan, a lead 
compound present in barley with a defined mechanism of action. 
Methods: Obesity was induced in male albino Wistar rats by feeding a high-fat diet (HFD) for 14 w and were randomly divided into four groups of 
equal number (n=6). Group 1 and 2 served as control fed with normal diet (5% fat). Group 3 and 4 were fed HFD (23%fat) for 14 w. In addition, 
group 2 and 4 rats were administered orally with 200 mg/kg body weight of barley β glucan (BRBG) from the third week. After 14 w, the rats were 
sacrificed, and serum/plasma levels of total cholesterol (TC), phospholipids, triglycerides (TG), high-density lipoprotein (HDL), low-density 
lipoprotein (LDL) and adiponectin were determined. 
Results: Biochemical changes were observed in weight gain, body mass index (BMI), adiposity index (ADI), total fat pad mass (TFP), blood lipids, 
LDL, lipid peroxides (LPO) and antioxidant enzyme activity of HFD fed rats when compared with BRBG co-administered rats. In addition, serum 
adiponectin levels and 3-hydroxy-3methyl-glutaryl-coenzyme A reductase (HMG CoA reductase) activity were elevated in rats administered BRBG 
along with HFD. Histological examination in HFD induced rats revealed a profound change in cell size with increased hypertrophy in visceral 
adipose tissue.  
Conclusions: The results indicate that barley consumption could reverse most of these biochemical and histological changes in HFD fed rats owing 
to its hypolipidemic and antioxidant effect.  
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Obesity is a pathological condition which is characterized by an 
increase in body weight that results in excessive fat accumulation. 
Obesity and hyperlipidemia are closely associated with the 
development of CVD, which is the main cause of death in developing 
countries [1]. 
Hyperlipidemia is a heterogeneous group of disorders 
characterized by an excess of lipids in the bloodstream. Frequent 
intake of HFD or increased endogenous biosynthesis of lipids are 
the major causes of hyperlipidemia. Increased lipogenesis together 
with hyperlipidemia and increased, fat deposition contribute to 
obesity [2]. 
BMI is an index of weight for height that is widely used to identify 
overweight and obesity. It is obtained by dividing a person's weight 
in kilograms by the square of the person's height in meters. 
Overweight and obesity are associated with more deaths worldwide 
and found to be an epidemic. People with obesity are at high risk of 
numerous health problems like heart attack from coronary heart 
failure, gallstones, congestive heart failure, stroke, high blood 
cholesterol, TG, hypertension and diabetes, which may cause 
sleeplessness and poor attention [3]. These multiple pathological 
alterations collectively facilitate the progress of atherosclerosis. 
Oxidative stress is highly associated with a wide variety of 
inflammatory and metabolic disease states, including obesity [4]. It 
is highly correlated with cumulative damage in the body done by 
free radicals inadequately neutralized by antioxidants thiobarbituric 
acid-reacting substances (TBARS) and hydroperoxides levels are 
markers of oxidative damage to cell membranes. Furthermore, 
oxidative damage is aggravated by the decrease in antioxidant 
enzyme activities such as superoxide dismutase (SOD), catalase 
(CAT), glutathione (GSH) and glutathione peroxidase (GPx) which 
acts as a free radical scavenger.  
Adipose tissue (AT) is not only acting as a simple energy depository 
tissue, but also as an active endocrine organ, releasing a variety of 
biologically active molecules known as adipocytokines or 
adipokines. Adiponectin, the first cloned protein hormone from AT is 
decreased in obese subjects and also functions to inhibit 
inflammatory processes [5]. Since adiponectin plays a crucial role in 
the pathogenesis of obesity-related complications, therapeutic drugs 
for the treatment of obesity should have the capacity to enhance the 
level of adiponectin. 
The chief goal of obesity treatment is to maintain a healthy weight. 
Use of allopathic and pharmacological drugs like Statin, Rimonabant 
and Sibutramine has become a popular means to overcome excess 
weight gain. Nevertheless, these drugs generally are effective with 
adverse side effects [6]. Hence naturally occurring phytochemicals 
such as dietary fibers present an exciting opportunity for the 
discovery of newer anti-obesity agents. 
Barley (Hordeum vulgare L.), a member of the grass family is a major 
cereal and first cultivated grains. β-glucan, a lead compound located 
primarily in the endosperm cell walls of barley is actively involved in 
the metabolic response to barley products [7]. β-glucan extracted 
from barley have been reported to possess various biological 
functions such as reducing blood lipids [8,9], blood glucose levels, 
enhancing insulin response [10], protecting against stress response 
[11] and restraining allergic reactions [12]. The aim of the present 
study is to evaluate the effect of BRBG on the level of blood lipids, 
adiponectin and HMG CoA reductase activity in diet-induced 
hyperlipidemia. 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 11, Issue 4, 2019 
Mumtaz et al. 
Int J Pharm Pharm Sci, Vol 11, Issue 4, 49-54 
50 
MATERIALS AND METHODS 
Chemicals and reagents 
ELISA kit used for the determination of serum adiponectin was 
purchased from Abcam, USA (ab108784). All other chemicals and 
reagents used were of analytical grade and were purchased from 
Sigma Aldrich, India and Excel Biosciences. Chennai-India. 
Animal maintenance 
Male Sprague Dawley rats (175-200 g) were individually housed in 
polycarbonate cage for 7 d under controlled conditions (22±2 
°C/RH 50±5%) in a 12:12 h L: D cycle and fed a standard pellet 
diet containing required amount of minerals and vitamins 
obtained from M/s: Provimi Animal Nutrition India Pvt Ltd., 
Bangalore for acclimatization. During the period diet and water 
were provided ad libitum. 
Experimental protocol 
After the acclimatization period, rats were randomly divided into 
four groups (n=6). Group 1 and 2 rats were fed a normal diet 
containing 5% fat. Group 3 and 4 rats were fed HFD containing 23% 
saturated fat for a period of 14 w. HFD was prepared and 
administered to rats, according to the report of Nascimento et al. 
[13]. The high purity ingredients (ground labina-439g, roasted 
peanuts-218g, casein-129g, corn oil-61g, French fried potatoes-153g 
per kg; purchased from Spencers Food World, Chennai, India) were 
with enough water and mixed with vitamins and minerals (1-1.2 g 
per 100g of HFD). The mixture was then made into pellets and dried 
in a ventilated drying oven at 55-65˚C. Rats were allowed for free 
access to food and water. Care was taken to monitor the food intake 
by rats every day. Rats were divided into four Groups. Group 1 and 2 
was fed with normal diet. Group 3 and 4 received HFD in 14 w. In 
addition group 2 and 4 rats were co-administered with 200 mg/kg 
body weight of BRBG by oral intubation from the third week 
onwards till the total experimental period of 14 w. The study 
protocol was approved by the Institutional Animal Ethics Committee 
(IAEC) (XIV/VELS/COL/43/CPCSEA/IAEC/15.03.2013). 
Body weight was measured weekly and the final body weight-to-
length ratio was also calculated for the determination of BMI. 
Length was measured between the nose and anus, not counting 
the tail. BMI was calculated by using the formula: BMI=body 
weight (g)/(nose-anus) (cm). At the end of the experimental 
period, the rats were anesthetized by injecting 0.1 ml/100g b. wt. 
Of ketamine/xylazine mixture (prepared by combining 1.5 ml of 
100 mg/ml xylazine and 10 ml of 100 mg/ml ketamine) and killed 
by cervical decapitation; immediately, blood was collected and the 
plasma/serum was separated by centrifugation and stored at 4 °C 
until analysis. AT was isolated and weighed from the epididymal, 
visceral and retroperitoneal fat pads. The sum of the entire fat pad 
mass was determined (TFP). ADI was also determined by using the 
formula: (sum of TFP/body weight) × 100 and expressed as 
adiposity percent (%). A portion of liver, heart and AT from each 
group was fixed in 10% formalin in saline for 24 h and used for 
histological studies. 
Collection and identification of barley grains 
Fresh barley grains were purchased from the local market in 
Chennai and authenticated by Dr. P. Jayaraman, Taxonomist, Plant 
Anatomy Research Centre. The voucher no: PARC/2015/3040 was 
allotted. The grains were washed, air dried and ground to fine 
powder and stored at room temperature. 
Preparation of BRBG 
β-Glucan was extracted from barley using the following basic 
procedure. First, the barley was crushed and then extracted with 
water (neutral), 50 mmol citrate buffer solute at pH 4.0 (acidic), or 
50 mmol carbonate buffer solution pH 9.0 (alkaline) conditions. 
After solid-liquid separation, the liquid phase was condensed. The 
extract was lyophilized, and β-glucan was obtained as a powder. 
Based on the yield and anti-oxidant properties the lyophilized 
extract of BRBG in acidic medium was used for the present study 
[14]. 
Estimation of biochemical parameters 
Serum adiponectin determination 
The serum adiponectin level was determined by using a quantitative 
ELISA kit (ab108784). The assay was performed as per the 
instructions of the kit manual. 
Assay of HMG CoA reductase 
The activity of HMG CoA reductase was assayed indirectly by 
assessing the ratio of HMG CoA to mevalonate in liver as described 
by Philipp and Shapiro [15]. The specific activity of the enzyme was 
expressed as the ratio of HMG CoA to mevalonate. The lower ratio 
indicates higher enzyme activity and vice versa. 
Lipid profile 
Zak’s method [16] was used for the TC. TG was estimated by the 
method of Van Handel and Zilversmit [17]. The sediment was 
centrifuged for 30 min at 1500g. An aliquot of clear supernatant was 
extracted with isopropanol; the extract was treated with a zeolite 
containing mixture to remove interfering substances, and the 
cholesterol concentration was then estimated. LDL was estimated by 
dual precipitation method [18]. The plasma was incubated with 
sodium dodecyl sulfate for 2 h and then centrifuged at 10,000g for 
10 min at 4˚C. Very low-density lipoprotein (VLDL) aggregated as a 
pellicle at the top. The supernatant containing a mixture of HDL and 
LDL was estimated in terms of cholesterol. 
Lipid peroxidation assay  
Liver and heart from all groups were collected at the end of the 
experimental period. 1g of each liver and heart sample was added to 
9 ml of normal saline 0.9 % and homogenized using electrical tissue 
Homogenizer and centrifuged at 3000g for 15 min. The supernatant 
was collected and used for the estimation of antioxidants such as 
CAT [19], SOD [20], GPx [21] and LPO was determined. The level of 
LPO in serum, heart and liver was determined by measuring TBARS 
by the method of Draper and Hadley [22]. The concentration of 
TBARS was expressed as nM/ml serum and nM/100 mg of tissue 
protein. 
Estimation of GSH 
GSH level was determined by the method of Moron et al. [23]. Equal 
volumes of ice-cold 5% trichloroacetic acid were added to the 
plasma and the precipitated proteins were removed by 
centrifugation. The supernatant was used for determination of GSH 
by using dithionitrobenzoic acid. 
Histopathological examinations 
Liver, heart and AT samples were fixed at 10% neutral buffered 
formalin for 24 h. Ultra-thin sections of the tissues were cut from 
embedded tissue blocks. The sections were then stained with 
hematoxylin-eosin and observed under a light microscope [24]. 
Statistical analysis 
Data were analyzed by using a commercially available statistical 
software package (SPSS for window V.10). The statistical 
significance of mean values between different groups was 
determined by applying one way ANOVA with post hoc Bonferroni 
test and the P value<0.05 was considered as significant. 
RESULTS 
Effect of BRBG on BMI, TFP and ADI in experimental rats 
Group 3 rats showed a significant (P=0.000) increase in BMI in HFD 
fed rats when compared to that of rats fed with normal diet (Group 
1). A significant decrease in BMI, TFP, and ADI were observed in 
BRBG co-administered rats shown in table 1. Control rats fed with 
normal diet and BRBG did not show any significant difference in 
these parameters when compared to normal Group 1 rats. 
Effect of BRBG on lipid profile 
Table 2 depicts the plasma levels of TC, TG, HDL and LDL, which was 
found to be significant (P=0.000) increased in Group 3 rats when 
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compared with Group 1 rats and a non-significant decrease in HDL 
cholesterol level was observed in rats fed with HFD when compared 
to control rats. BRBG co-administered rats showed a significant 
(P=0.000) increase in HDL cholesterol than in rats fed only HFD. 
 
Table 1: Effect of BRBG on weight gain, BMI, TFP mass and ADI in control and experimental rats 
Groups Net weight gain (g) (final-initial) BMI (g/cm2) TFP (g) ADI (%) 
Control 155.4±12.3 0.61±11. 2 15.3±13.2 4.34±10.2 
BRBG Control 152.3±12.2NS 0.60±12.4NS 13.7±13.4NS 4.21±10.4NS 
HFD 285±12.6* 1.50±11.4* 27.4±13.6* 6.92±10.6* 
HFD+BRBG 177.4±12.8* 0.76±11.6* 12.8±13.8* 5.74±10.8* 
Data were expressed by one-way ANOVA followed by post hoc Bonferroni test. Values are expressed as mean±SD for 6 animals in each group. 
Statistical significance was calculated by comparing control Vs BRBG control, control Vs HFD and HFD Vs HFD+BRBG. *P=0.000, NS= non-significant 
 
Table 2: Effect of BRBG on serum TC, TG and lipoprotein levels 
Groups TC (mg/dl) TG (mg/dl) HDL (mg/dl) LDL (mg/dl) LDL: HDL ratio 
Control 69.41±9.37 96.3±9.72 27.3±3.49 15.7±2.13 0.58±0.07 
BRBG Control 67.12±8.26NS 94.6±12.96NS 28.4±2.87NS 14.1±1.62NS 0.50±0.06 NS 
HFD 144.65±20.83* 155.1±19.23* 15.9±2.20* 25.3±3.47* 1.59±0.18* 
HFD+BRBG 102.19±12.26* 117.4±12.06* 21.5±2.45* 20.8±2.58* 0.96±0.14* 
Data were expressed by one-way ANOVA followed by post hoc Bonferroni test. Values are expressed as mean±SD for 6 animals in each group. Statistical 
significance was calculated by comparing control Vs BRBG control, control Vs HFD and HFD Vs HFD+BRBG. *P =0.000, NS = non–significant 
 
Effect of BRBG on activity of HMG CoA reductase 
The activity of HMG CoA reductase was assayed indirectly by 
assessing the ratio of HMG CoA to mevalonate in hepatic tissue is 
shown in table 3. The lower ratio indicates higher enzyme activity 
and vice versa. In the present investigation, this ratio was found to 
be decreased in HFD fed rats when compared with BRBG co-
administered rats. There was no significant difference (P=1.000) 
between Group1 and Group 2 rats. 
Effect of BRBG on serum adiponectin levels 
The serum adiponectin level is shown in fig. 1. A significant decrease 
in adiponectin level was found in HFD fed control rats. The BRBG co-
administration was identified to increase the serum adiponectin 
level significantly (P=0.77). 
In table 4 and 5 it is shown that there is a strong correlation 
between the occurrence of obesity and free radical production, as in 
untreated HFD induced rats (Group 3), the levels of LPO and GSH 
was found to be decreased which serves as an effective indicator of 
oxidative stress. Interestingly, the present study showed that barley 
consumption significantly increased (P=0.000) the level of LPO and 
GSH in experimental animals. 
Histopathological examinations 
The light microscopic examination of liver tissue of control is shown 
in fig. 2A and drug control (fig. 2B) group revealed almost same 
histological changes. A high degree of steatosis, fat deposition, 
inflammation and accumulation of lipid droplets (fig. 2C) were found 
in group 3 rats. Fig. 2D shows that the administration of BRBG along 
with HFD restored the normal appearance of liver tissue by reducing 
necrosis and inflammation. 
 
Table 3: Activity levels, of HMG CoA reductase in the liver tissue of different groups of rats 
Groups Liver (Ratio of HMG CoA to mevalonate) *** 
Control 4.25±0.47 
BRBG Control 3.75±0.48NS 
HFD 2.66±0.36* 
HFD+BRBG 6±0.202* 
Data were expressed by one-way ANOVA followed by post hoc Bonferroni test. Values are expressed as mean±SD for 6 animals in each group. 
Statistical significance was calculated by comparing control Vs BRBG control, control Vs HFD and HFD Vs HFD+BRBG. ***Lower ratio indicates higher 
enzyme activity and vice versa. *P=0.000, NS= non-significant 
 
 
Fig. 1: Values are expressed as mean±SD for 6 animals in each group. Statistically significant variations were derived when Group 1 was 
compared with Group 2 and Group 3, and Group 3 was compared with Group 4. Values were expressed as *P=0.000, NS = non-significant 
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Table 4: Levels of lipid peroxidation products in serum, heart and liver of experimental animals 
Groups Serum (μM/ml) Heart nm MDA/mg of protein Liver nm MDA/mg of protein 
Control 8.33±0.866 59.2±6.98 89.5±9.75 
BRBG Control 7.9±0.97NS 58.4±7.41NS 89±12.56NS 
HFD 10.8±1.34* 70.3±9.56a 109±14.72 b 
HFD+BRBG 8.23±1.06* 58.9±8.65 c 90.2±10.28 d 
Data were expressed by one-way ANOVA followed by post hoc Bonferroni test. Values are expressed as mean±SD for 6 animals in each group. 
Statistical significance was calculated by comparing control Vs BRBG control, control Vs HFD and HFD Vs HFD+BRBG. *P=0.000, aP =. 022, bP=. 007, 
cP=. 018, dP=0.010, NS = non-significant. 
 
Table 5: Levels of reduced GSH in the serum, heart and liver of experimental animals 
Groups Serum mg/g of protein Liver mg/g of protein Heart mg/g of protein 
Control 4±0.245 16.33±1.93 9.89±1.32 
BRBG Control 3.33±0.35 NS 15±2.13NS 8.21±1.2 NS 
HFD 2±0.22*  7.85±1.1 * 3.51±0.36 ** 
HFD+BRBG 5.33±0.564 * 16.20±2.1 * 8.90±1.3 * 
Data were expressed by one-way ANOVA followed by post hoc Bonferroni test. Values are expressed as mean±SD for 6 animals in each group. Statistical 
significance was calculated by comparing control Vs BRBG control, control Vs HFD and HFD Vs HFD+BRBG. *P=0.000, **P=. 124, NS = non-significant. 
 
 
Fig. 2: Photomicrograph of liver showing normal tissue architecture in control rats (A) and no significant pathological alteration in BRBG 
control rats (B). A high degree of steatosis and fatty infiltration in HFD fed rats (C). Very mild inflammation and fatty changes in HFD and 
BRBG treated rats (D) 
 
 
Fig. 3: The light microscopic examination showing normal tissue architecture of the heart in control rats (A). BRBG control rats showing 
normal tissue with no pathological changes (B). Rats which received HFD (C) showing fat deposition and degenerated necrotic cells, 
whereas BRBG (D) co-administration showing only mild degeneration were observed in the heart sections 
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The tissue architecture of heart tissue of control (fig. 3A) and BRBG 
control (fig. 3B) rats show normal tissue with no pathological 
changes. Rats which received HFD (fig. 3C) showed fat deposition 
and degenerated necrotic cells when compared with BRBG co-
administered rats (fig. 3D). Visceral adipose tissue has shown an 
abnormal increase in adipocyte cell size (fig. 4C) in HFD fed rats, 
whereas BRBG co-administered rats showed an improved adipocyte 
size (fig. 4D). 
 
 
Fig. 4: The light microscopic examination showing normal sized adipose cells were observed in control rats (A) and BRBG control rats (B). For 
HFD fed rats (C) the hypertrophy condition (Increased cell size) exists. BRBG co-administered rats showed an improved adipocyte size (D) 
 
DISCUSSION 
Obesity is a strong risk factor for developing dyslipidemia, diabetes 
mellitus and CVD. Feeding of HFD to rats was found to be a useful 
model of putative effects of dietary fats in humans. In the present 
study, the weight gained by rats fed HFD formula was significantly 
more than those gained by a control group of rats fed a normal diet. 
The BMI, TFP and ADI were found well maintained in rats that 
received BRBG probably by its active components which exert 
hypolipidemic activity [25]. 
HFD resulted in dyslipidemic changes as illustrated by increasing serum 
levels of TG, TC, LDL cholesterol and low level of HDL cholesterol as 
compared with control and BRBG co-administered rats. In addition, the 
enzyme HMG CoA reductase converts HMG CoA to mevalonate in 
cholesterol biosynthesis. The lower ratio points to higher enzyme 
activity and vice versa. In the current study, this ratio was found to be 
decreased in HFD fed rats when compared with BRBG received rats. 
The main mechanism for BRBG cholesterol-lowering effect is 
thought to be dependent on its ability to entrap whole micelles 
containing bile acid in the intestinal contents due to its viscosity and 
excluding them from the required interaction with the luminal 
membrane transporters on the intestinal epithelium, thereby 
decreasing the absorption or re-absorption of fats, including 
cholesterol and bile acid, which leads to an increased fecal output 
and catabolism of cholesterol. This further leads to increased 
activities of 7α-hydroxylase and HMG CoA reductase to compensate 
for the loss of bile acids and cholesterol from liver stores. Similar 
results were observed by Aly et al., [26] who reported that the 
supplementation of diet with either oat or barley bran resulted in a 
significant decrease in the level of serum total lipid, TC, TG, LDL, 
VLDL, and LDL/HDL ratio with an increase in the level of HDL 
compared with those fed high cholesterol alone. 
Adiponectin is the most abundant adipokine secreted by adipose 
cells that may couple regulation of insulin sensitivity with energy 
metabolism. Adiponectin is a 30 KD protein that consists of a N-
terminal collagenous domain and a C-terminal globular domain. This 
globular domain of adiponectin is pharmacologically active and can 
regulate body weight and fatty acid oxidation [27]. From the current 
study, it is clear that the level of adiponectin has been inversely 
correlated with obesity. Reduced serum adiponectin levels are 
observed in patients with diabetes mellitus, metabolic syndrome 
and coronary heart disease and this may play a key role in the 
development of obesity. Increased adiponectin level in BRBG treated 
rats (Group 4) support the concept that it has a distinct potential for 
being a therapeutic drug for the treatment of obesity-related 
diseases, indicates the metabolic syndrome to malignancies. 
Oxidative stress is closely associated with a wide variety of 
inflammatory and metabolic disease states, including obesity. TBARS 
and hydroperoxides levels are markers of oxidative damage of cell 
membranes. Lipid peroxidation is considered as a component of 
obesity-induced pathology. The data reported in this study showed 
increased lipid peroxidation in serum, hepatic and cardiac tissues as 
expressed by increased levels of malondialdehyde (MDA). The 
current results are in basic agreement with the results of Amirkhizi 
et al., [28] who showed that obesity is associated with an increase in 
lipid peroxidation and the decrease in the activity of cytoprotective 
enzymes. The potential mechanism for increased lipid peroxidation 
in cardiac tissue may be a result of increased lipid substrate within 
the myocardium, which serves as a larger target for oxidation by 
free radicals. Hence the oxidized LDL was attracted by 
monocytes/macrophages, resulting in atherosclerotic plagues.  
GSH is a water-soluble tripeptide composed of the amino acids 
glutamine, cysteine, and glycine. GSH also functions as a free radical 
scavenger and in the repair of radical caused biological damage. 
Reduced GSH in liver, heart and blood in HFD fed rats represented 
increased utilization due to oxidative stress. On the contrary BRBG 
succeeded in antagonizing the oxidative stress induced by HFD to a 
greater extent [29]. 
Histological changes induced by HFD in liver, heart and AT of 
experimental rats were consistently alleviated by BRBG proving its 
hepatoprotective and hypolipidemic property. 
CONCLUSION 
In conclusion, the present study showed that β-glucan of barley can 
be accounted for the hypolipidemic and anti-obesity effect of barley. 
It can be recommended that barley can be included in the everyday 
diet of hyperlipidemia and obese individuals to minimize the 
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complications such as hypertension, type II diabetes mellitus and 
CVD. The low cost and easy availability of barley can replace high 
cost statin drugs with side effects on long term consumption. 
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